
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $27.6M | $49M | $71.3M | $81.1M | $79.9M | |
Revenue Growth (YoY) | 18.38% | 77.12% | 45.7% | 13.63% | -1.47% | |
Cost of Revenues | $9.2M | $8.6M | $12.4M | $11.9M | $11.6M | |
Gross Profit | $18.4M | $40.3M | $59M | $69.2M | $68.3M | |
Gross Profit Margin | 66.68% | 82.41% | 82.67% | 85.34% | 85.5% | |
R&D Expenses | $8.9M | $15.6M | $22.9M | $17.6M | $18M | |
Selling, General & Admin | $41.7M | $76.2M | $120.1M | $108.9M | $100.8M | |
Other Inc / (Exp) | -$71K | -$6.9M | $2.2M | $7.2M | $3.9M | |
Operating Expenses | $50.6M | $91.8M | $142.9M | $126.4M | $118.8M | |
Operating Income | -$32.2M | -$51.5M | -$84M | -$57.3M | -$50.5M | |
Net Interest Expenses | $2.4M | $4.4M | $4.5M | $5.4M | $4.7M | |
EBT. Incl. Unusual Items | -$34.6M | -$62.8M | -$86.2M | -$55.4M | -$51.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $61K | $188K | $47K | $110K | $236K | |
Net Income to Company | -$34.7M | -$63M | -$86.2M | -$55.5M | -$51.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$34.7M | -$63M | -$86.2M | -$55.5M | -$51.5M | |
Basic EPS (Cont. Ops) | -$0.99 | -$2.36 | -$1.80 | -$1.14 | -$1.03 | |
Diluted EPS (Cont. Ops) | -$0.99 | -$2.36 | -$1.80 | -$1.14 | -$1.03 | |
Weighted Average Basic Share | $35.1M | $26.7M | $47.8M | $48.6M | $50.1M | |
Weighted Average Diluted Share | $35.1M | $26.7M | $47.8M | $48.6M | $50.1M | |
EBITDA | -$31.7M | -$57.8M | -$81M | -$49.4M | -$45.9M | |
EBIT | -$32.2M | -$58.4M | -$81.7M | -$50M | -$46.6M | |
Revenue (Reported) | $27.6M | $49M | $71.3M | $81.1M | $79.9M | |
Operating Income (Reported) | -$32.2M | -$51.5M | -$84M | -$57.3M | -$50.5M | |
Operating Income (Adjusted) | -$32.2M | -$58.4M | -$81.7M | -$50M | -$46.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $8.6M | $14.9M | $18.8M | $19.3M | $17.5M | |
Revenue Growth (YoY) | 32.93% | 72.33% | 26.5% | 2.34% | -9.12% | |
Cost of Revenues | $2.3M | $3M | $3M | $2.8M | $2.4M | |
Gross Profit | $6.3M | $11.8M | $15.8M | $16.5M | $15.1M | |
Gross Profit Margin | 73.35% | 79.62% | 83.81% | 85.5% | 86.21% | |
R&D Expenses | $3.4M | $5.6M | $4.7M | $4.6M | $4.4M | |
Selling, General & Admin | $14.6M | $28.4M | $28.7M | $26.6M | $24.5M | |
Other Inc / (Exp) | $552K | -$15K | $1.8M | -$322K | $1M | |
Operating Expenses | $18M | $34M | $33.3M | $31.2M | $29M | |
Operating Income | -$11.7M | -$22.2M | -$17.6M | -$14.7M | -$13.9M | |
Net Interest Expenses | $1.1M | $1M | $1.3M | $1.2M | $1.3M | |
EBT. Incl. Unusual Items | -$12.2M | -$23.3M | -$17.1M | -$16.2M | -$14.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $52K | $9K | $14K | $17K | $41K | |
Net Income to Company | -$12.2M | -$23.3M | -$17.1M | -$16.3M | -$14.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$12.2M | -$23.3M | -$17.1M | -$16.3M | -$14.2M | |
Basic EPS (Cont. Ops) | -$0.29 | -$0.49 | -$0.35 | -$0.33 | -$0.28 | |
Diluted EPS (Cont. Ops) | -$0.29 | -$0.49 | -$0.35 | -$0.33 | -$0.28 | |
Weighted Average Basic Share | $42.2M | $47.6M | $48.4M | $49.5M | $51.3M | |
Weighted Average Diluted Share | $42.2M | $47.6M | $48.4M | $49.5M | $51.3M | |
EBITDA | -$11M | -$22M | -$15.6M | -$14.9M | -$12.7M | |
EBIT | -$11.1M | -$22.2M | -$15.8M | -$15M | -$12.9M | |
Revenue (Reported) | $8.6M | $14.9M | $18.8M | $19.3M | $17.5M | |
Operating Income (Reported) | -$11.7M | -$22.2M | -$17.6M | -$14.7M | -$13.9M | |
Operating Income (Adjusted) | -$11.1M | -$22.2M | -$15.8M | -$15M | -$12.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $29.8M | $55.2M | $75.3M | $81.5M | $78.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $9.4M | $9.3M | $12.4M | $11.6M | $11.2M | |
Gross Profit | $20.4M | $45.9M | $62.9M | $69.9M | $66.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $9.9M | $17.8M | $21.9M | $17.5M | $17.8M | |
Selling, General & Admin | $45.6M | $90M | $120.3M | $106.8M | $98.8M | |
Other Inc / (Exp) | $390K | -$7.5M | $4M | $5.1M | $5.3M | |
Operating Expenses | $55.5M | $107.9M | $142.2M | $124.3M | $116.6M | |
Operating Income | -$35.1M | -$62M | -$79.3M | -$54.4M | -$49.7M | |
Net Interest Expenses | $2.9M | $4.3M | $4.7M | $5.3M | $4.7M | |
EBT. Incl. Unusual Items | -$37.7M | -$73.8M | -$80M | -$54.6M | -$49.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $82K | $145K | $52K | $113K | $260K | |
Net Income to Company | -$37.8M | -$74M | -$80M | -$54.7M | -$49.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$37.8M | -$74M | -$80M | -$54.7M | -$49.4M | |
Basic EPS (Cont. Ops) | -$1.02 | -$1.68 | -$1.66 | -$1.12 | -$0.98 | |
Diluted EPS (Cont. Ops) | -$1.02 | -$1.68 | -$1.66 | -$1.12 | -$0.98 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$33.9M | -$68.8M | -$74.6M | -$48.6M | -$43.7M | |
EBIT | -$34.7M | -$69.5M | -$75.3M | -$49.3M | -$44.4M | |
Revenue (Reported) | $29.8M | $55.2M | $75.3M | $81.5M | $78.1M | |
Operating Income (Reported) | -$35.1M | -$62M | -$79.3M | -$54.4M | -$49.7M | |
Operating Income (Adjusted) | -$34.7M | -$69.5M | -$75.3M | -$49.3M | -$44.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $8.6M | $14.9M | $18.8M | $19.3M | $17.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.3M | $3M | $3M | $2.8M | $2.4M | |
Gross Profit | $6.3M | $11.8M | $15.8M | $16.5M | $15.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.4M | $5.6M | $4.7M | $4.6M | $4.4M | |
Selling, General & Admin | $14.6M | $28.4M | $28.7M | $26.6M | $24.5M | |
Other Inc / (Exp) | $552K | -$15K | $1.8M | -$322K | $1M | |
Operating Expenses | $18M | $34M | $33.3M | $31.2M | $29M | |
Operating Income | -$11.7M | -$22.2M | -$17.6M | -$14.7M | -$13.9M | |
Net Interest Expenses | $1.1M | $1M | $1.3M | $1.2M | $1.3M | |
EBT. Incl. Unusual Items | -$12.2M | -$23.3M | -$17.1M | -$16.2M | -$14.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $52K | $9K | $14K | $17K | $41K | |
Net Income to Company | -$12.2M | -$23.3M | -$17.1M | -$16.3M | -$14.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$12.2M | -$23.3M | -$17.1M | -$16.3M | -$14.2M | |
Basic EPS (Cont. Ops) | -$0.29 | -$0.49 | -$0.35 | -$0.33 | -$0.28 | |
Diluted EPS (Cont. Ops) | -$0.29 | -$0.49 | -$0.35 | -$0.33 | -$0.28 | |
Weighted Average Basic Share | $42.2M | $47.6M | $48.4M | $49.5M | $51.3M | |
Weighted Average Diluted Share | $42.2M | $47.6M | $48.4M | $49.5M | $51.3M | |
EBITDA | -$11M | -$22M | -$15.6M | -$14.9M | -$12.7M | |
EBIT | -$11.1M | -$22.2M | -$15.8M | -$15M | -$12.9M | |
Revenue (Reported) | $8.6M | $14.9M | $18.8M | $19.3M | $17.5M | |
Operating Income (Reported) | -$11.7M | -$22.2M | -$17.6M | -$14.7M | -$13.9M | |
Operating Income (Adjusted) | -$11.1M | -$22.2M | -$15.8M | -$15M | -$12.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $61.5M | $260.7M | $185M | $138.1M | $120.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $5.4M | $8.7M | $15.1M | $14.3M | $10.8M | |
Inventory | $2.6M | $3.5M | $6.1M | $7.8M | $6.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.2M | $4.2M | $3.4M | $2.6M | $2.3M | |
Total Current Assets | $70.6M | $277M | $209.7M | $162.9M | $139.8M | |
Property Plant And Equipment | $1.8M | $2.9M | $3.2M | $3.1M | $2.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $386K | $202K | $211K | $682K | $550K | |
Total Assets | $72.8M | $280.2M | $213.1M | $166.7M | $142.8M | |
Accounts Payable | $2.2M | $3.4M | $2.7M | $1.7M | $1.7M | |
Accrued Expenses | $2.7M | $3.7M | $6.7M | $3.2M | $3.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $2.2M | -- | |
Current Portion Of Capital Lease Obligations | $395K | $510K | $1M | $573K | $533K | |
Other Current Liabilities | -- | -- | $2K | -- | -- | |
Total Current Liabilities | $9.3M | $13.5M | $17.8M | $12.3M | $15.5M | |
Long-Term Debt | $32M | $32.7M | $33.3M | $31.7M | $39.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $161.7M | $48.1M | $53M | $46.4M | $55.3M | |
Common Stock | $9K | $48K | $48K | $49K | $51K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -$88.8M | $232.1M | $160.1M | $120.2M | $87.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$88.8M | $232.1M | $160.1M | $120.2M | $87.5M | |
Total Liabilities and Equity | $72.8M | $280.2M | $213.1M | $166.7M | $142.8M | |
Cash and Short Terms | $61.5M | $260.7M | $185M | $138.1M | $120.4M | |
Total Debt | $32M | $32.7M | $33.3M | $33.9M | $39.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $48.3M | $238.6M | $167.3M | $127.3M | $108.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $5.6M | $9.9M | $16.4M | $15.6M | $9.4M | |
Inventory | $2.5M | $4.1M | $7.1M | $6.9M | $5.8M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1M | $2.7M | $2.8M | $2.3M | $2.9M | |
Total Current Assets | $57.5M | $255.3M | $193.7M | $152.1M | $126.9M | |
Property Plant And Equipment | $1.6M | $3.1M | $2.8M | $2.8M | $2.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $1.4M | $191K | $224K | $624K | $472K | |
Total Assets | $60.5M | $258.6M | $196.6M | $155.6M | $129.7M | |
Accounts Payable | $3M | $3.1M | $3.5M | $1.7M | $2.8M | |
Accrued Expenses | $3.8M | $4.5M | $5.6M | $5.5M | $3.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $248K | $534K | $1.1M | $509K | $552K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $9.3M | $12M | $15.1M | $11.7M | $12.1M | |
Long-Term Debt | $32.1M | $32.8M | $33.5M | $33.7M | $39.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $161.3M | $46.7M | $50.3M | $46.4M | $52.1M | |
Common Stock | $9K | $48K | $48K | $50K | $51K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$100.8M | $211.9M | $146.4M | $109.2M | $77.6M | |
Total Liabilities and Equity | $60.5M | $258.6M | $196.6M | $155.6M | $129.7M | |
Cash and Short Terms | $48.3M | $238.6M | $167.3M | $127.3M | $108.8M | |
Total Debt | $32.1M | $32.8M | $33.5M | $33.7M | $39.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$34.7M | -$63M | -$86.2M | -$55.5M | -$51.5M | |
Depreciation & Amoritzation | $554K | $632K | $710K | $614K | $712K | |
Stock-Based Compensation | $497K | $5.1M | $13M | $14.6M | $17.1M | |
Change in Accounts Receivable | -$1.5M | -$3.7M | -$6.8M | $661K | $3.5M | |
Change in Inventories | -$1.7M | -$1.3M | -$3.3M | -$2.2M | $1.6M | |
Cash From Operations | -$32.2M | -$52.5M | -$76M | -$47.2M | -$22.4M | |
Capital Expenditures | $953K | $813K | $970K | $791K | $385K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$953K | -$813K | -$970K | -$791K | -$385K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $20.5M | -- | -- | -- | $39.5M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$35.4M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$184K | -$4.5M | -- | -$224K | -$261K | |
Cash From Financing | $73.4M | $252.5M | $1.2M | $1.1M | $5M | |
Beginning Cash (CF) | $21.2M | $61.5M | $260.7M | $185M | $138.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $40.3M | $199.2M | -$75.7M | -$46.9M | -$17.8M | |
Ending Cash (CF) | $61.5M | $260.7M | $185M | $138.1M | $120.4M | |
Levered Free Cash Flow | -$33.1M | -$53.4M | -$76.9M | -$48M | -$22.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$12.2M | -$23.3M | -$17.1M | -$16.3M | -$14.2M | |
Depreciation & Amoritzation | $135K | $179K | $146K | $192K | $149K | |
Stock-Based Compensation | $277K | $3M | $3.5M | $4.5M | $4.2M | |
Change in Accounts Receivable | -$301K | -$1.2M | -$959K | -$1.4M | $1.3M | |
Change in Inventories | -$146K | -$615K | -$1M | $1M | $541K | |
Cash From Operations | -$12.9M | -$22M | -$17.4M | -$9.8M | -$11.6M | |
Capital Expenditures | $104K | $227K | $126K | $117K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$104K | -$227K | -$126K | -$117K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $34.5M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$35.4M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$223K | -- | -$205K | -$238K | -$47K | |
Cash From Financing | -$210K | $92K | -$156K | -$942K | $16K | |
Beginning Cash (CF) | $61.5M | $260.7M | $185M | $138.1M | $120.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$13.2M | -$22.1M | -$17.7M | -$10.8M | -$11.6M | |
Ending Cash (CF) | $48.3M | $238.6M | $167.3M | $127.3M | $108.8M | |
Levered Free Cash Flow | -$13M | -$22.2M | -$17.5M | -$9.9M | -$11.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$37.8M | -$74M | -$80M | -$54.7M | -$49.4M | |
Depreciation & Amoritzation | $546K | $676K | $677K | $660K | $669K | |
Stock-Based Compensation | $713K | $7.8M | $13.5M | $15.6M | $16.8M | |
Change in Accounts Receivable | -$2M | -$4.6M | -$6.6M | $230K | $6.3M | |
Change in Inventories | -$1.7M | -$1.8M | -$3.7M | -$117K | $1.2M | |
Cash From Operations | -$35.5M | -$61.6M | -$71.4M | -$39.6M | -$24.2M | |
Capital Expenditures | $544K | $936K | $869K | $782K | $268K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$544K | -$936K | -$869K | -$782K | -$268K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $34.5M | $5M | |
Long-Term Debt Repaid | -- | -- | -- | -$35.4M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$310K | -- | -- | -$257K | -$70K | |
Cash From Financing | $43.1M | $252.8M | $1M | $318K | $5.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $7.1M | $190.3M | -$71.3M | -$40.1M | -$18.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$36M | -$62.6M | -$72.3M | -$40.4M | -$24.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$12.2M | -$23.3M | -$17.1M | -$16.3M | -$14.2M | |
Depreciation & Amoritzation | $135K | $179K | $146K | $192K | $149K | |
Stock-Based Compensation | $277K | $3M | $3.5M | $4.5M | $4.2M | |
Change in Accounts Receivable | -$301K | -$1.2M | -$959K | -$1.4M | $1.3M | |
Change in Inventories | -$146K | -$615K | -$1M | $1M | $541K | |
Cash From Operations | -$12.9M | -$22M | -$17.4M | -$9.8M | -$11.6M | |
Capital Expenditures | $104K | $227K | $126K | $117K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$104K | -$227K | -$126K | -$117K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $34.5M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$35.4M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$223K | -- | -$205K | -$238K | -$47K | |
Cash From Financing | -$210K | $92K | -$156K | -$942K | $16K | |
Beginning Cash (CF) | $61.5M | $260.7M | $185M | $138.1M | $120.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$13.2M | -$22.1M | -$17.7M | -$10.8M | -$11.6M | |
Ending Cash (CF) | $48.3M | $238.6M | $167.3M | $127.3M | $108.8M | |
Levered Free Cash Flow | -$13M | -$22.2M | -$17.5M | -$9.9M | -$11.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.